Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

Summary

The primary objective is to assess the safety and effectiveness of Pyridoxal 5'-Phosphate on the reduction of expressed symptoms of tardive dyskinesia in patients with schizophrenia and schizoaffective disorders.

Timeline

Start

2009-05

Primary completion

2012-08

Completion

2014-08

Outcome

Outcome not reported

Stopped: “modified formulation under investigation”

Drugs

Indications